Stock Earnings

Question 1

Merck & Co Inc의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Merck & Co Inc의 총 자산은 $117,106이며, 순profit입니다.

Question 2

MRK의 주요 재무 비율은 무엇인가요?

Accepted Answer

Merck & Co Inc의 유동비율은 1.65이고, 순이익률은 26.67, 주당 매출은 $25.25입니다.

Question 3

Merck & Co Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Merck & Co Inc largest revenue segment is Pharmaceutical, at a revenue of 57,400,000,000 in the most earnings release.For geography, United States is the primary market for Merck & Co Inc, at a revenue of 32,277,000,000.

Question 4

Merck & Co Inc은 수익성이 있나요?

Accepted Answer

yes, 최신 재무제표에 따르면 Merck & Co Inc의 순profit은 $17,117입니다.

Question 5

Merck & Co Inc에 부채가 있나요?

Accepted Answer

yes, Merck & Co Inc의 부채는 70,793입니다.

Question 6

Merck & Co Inc의 발행 주식은 몇 주인가요?

Accepted Answer

Merck & Co Inc의 총 발행 주식은 2,527.63주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	64,235	64,168	60,115	59,283	48,704	41,518
Revenue Growth (YoY)	2%	7%	1%	22%	17%	6%
Cost of Revenue	13,671	14,698	15,915	17,206	13,241	11,583
Gross Profit	50,564	49,470	44,200	42,077	35,463	29,935
Selling, General & Admin	10,647	10,733	10,382	9,948	9,615	8,908
Research & Development	15,459	14,442	12,663	11,818	10,254	10,102
Operating Expenses	26,106	25,175	23,045	21,766	19,869	19,010
Other Non Operating Income (Expenses)	614	1,093	917	960	468	469
Pretax Income	21,817	19,936	1,889	16,444	13,879	5,863
Income Tax Expense	2,773	2,803	1,512	1,918	1,521	1,340
Net Income	19,034	17,117	365	14,519	13,049	7,067
Net Income Growth	56.99%	4,590%	-97%	11%	85%	-28%
Shares Outstanding (Diluted)	2,498	2,541	2,547	2,542	2,538	2,541
Shares Change (YoY)	-2%	0%	0%	0%	0%	-2%
EPS (Diluted)	7.61	6.74	0.14	5.71	5.14	2.78
EPS Growth	59%	4,714%	-98%	11%	85%	-27%
Free Cash Flow	--	18,096	9,143	14,707	9,661	5,824
Free Cash Flow Per Share	--	7.12	3.58	5.78	3.8	2.29
Gross Margin	78.71%	77.09%	73.52%	70.97%	72.81%	72.1%
Operating Margin	38.07%	37.86%	35.19%	34.26%	32.01%	26.31%
Profit Margin	29.63%	26.67%	0.6%	24.49%	26.79%	17.02%
Free Cash Flow Margin	--	28.2%	15.2%	24.8%	19.83%	14.02%
EBITDA	--	28,794	25,027	24,220	18,808	14,411
EBITDA Margin	--	44.87%	41.63%	40.85%	38.61%	34.71%
D&A For EBITDA	--	4,499	3,872	3,909	3,214	3,486
EBIT	24,458	24,295	21,155	20,311	15,594	10,925
EBIT Margin	38.07%	37.86%	35.19%	34.26%	32.01%	26.31%
Effective Tax Rate	12.71%	14.05%	80.04%	11.66%	10.95%	22.85%

Merck & Co Inc (MRK) Price

MRK Stock Price Chart

MRK Income

Follow-Up Questions